Large drugmakers

The 412 large drugmakers we cover, part of healthcare, largest first. Numbers as of Oct 24, 2026.

Companies: 412
Combined market cap: $3.9T
Median PE: 24.2×
Median revenue growth: +6.8%
Median net margin: −7.3%

Company	Market cap	PE	P/S	Revenue growth	Net margin	Dividend yield
LLYEli Lilly and	$1.2T	42.7×	15.0×	+50%	33.5%	0.53%
JNJJohnson & Johnsoncaveat	$635.8B	40.0×	6.4×	+8%	n/m	2.00%
ABBVAbbVie	$504.8B	80.7×	7.8×	+10%	9.8%	2.42%
MRKMerck	$358.4B	116×	5.4×	+5%	4.8%	2.34%
AMGNAmgen	$237.5B	27.3×	6.2×	+9%	23.0%	2.26%
GILDGilead Sciences	$193.5B	n/m	6.4×	+6%	−10.6%	2.08%
PFEPfizer	$171.2B	39.5×	2.7×	−0%	6.8%	5.73%
BMYBristol-Myers Squibb	$125.6B	13.5×	2.6×	+3%	18.9%	4.10%
BIIBBiogen	$37B	44.4×	3.7×	+0%	8.3%	n/m
JAZZJazz Pharmaceuticals	$13.9B	14.6×	3.0×	+13%	20.4%	n/m
BBIOBridgeBio Pharma	$13.4B	n/m	18.8×	+202%	−97.0%	n/m
SMMTSummit Therapeutics	$12.3B	n/m	n/m	n/m	n/m	n/m
ELANElanco Animal Health	$11.3B	n/m	2.2×	+12%	−4.0%	n/m
BMRNBiomarin Pharmaceutical	$10.8B	151×	3.2×	+11%	2.1%	n/m
MDGLMadrigal Pharmaceuticals	$10B	n/m	7.8×	+149%	−25.3%	n/m
CORTCorcept Therapeutics	$9.3B	204×	11.2×	+16%	6.6%	n/m
PTGXProtagonist Therapeutics	$9B	134×	31.8×	+35%	29.4%	n/m
CYTKCytokinetics	$8.5B	n/m	126×	−21%	n/m	n/m
TGTXTG Therapeutics	$8.3B	19.8×	10.4×	+76%	55.2%	n/m
ARWRArrowhead Pharmaceuticals	$8.2B	n/m	12.2×	+17%	−47.8%	n/m
SYRESpyre Therapeutics	$8B	n/m	n/m	n/m	n/m	n/m
AXSMAxsome Therapeutics	$7.6B	n/m	9.8×	+57%	−24.7%	n/m
ALKSAlkermes plc.	$7.3B	115×	4.4×	+11%	4.0%	n/m
IONSIonis Pharmaceuticals	$7.1B	n/m	8.2×	−7%	−64.7%	n/m
PRAXPraxis Precision Medicinescaveat	$7.1B	n/m	n/m	n/m	n/m	n/m
AMRXAmneal Pharmaceuticals	$6.5B	41.6×	2.1×	+9%	5.0%	n/m
RYTMRhythm Pharmaceuticals	$6.1B	n/m	25.6×	+54%	−85.6%	n/m
LGNDLigand Pharmaceuticals	$6.1B	32.3×	20.8×	+55%	67.9%	n/m
KNSAKiniksa Pharmaceuticals International	$6B	79.1×	7.1×	+59%	9.6%	n/m
MANEVeradermicscaveat	$5.8B	n/m	n/m	n/m	n/m	n/m
COGTCogent Biosciences	$5.4B	n/m	n/m	n/m	n/m	n/m
ORKAOruka Therapeutics	$5.3B	n/m	n/m	n/m	n/m	n/m
MIRMMirum Pharmaceuticals	$5.2B	n/m	8.4×	+44%	n/m	n/m
PTCTPTC Therapeutics	$5.1B	n/m	5.0×	−43%	−3.8%	n/m
ERASErasca	$5B	n/m	n/m	n/m	n/m	n/m
TVTXTravere Therapeuticscaveat	$4.7B	n/m	8.0×	+77%	−7.4%	n/m
DNTHDianthus Therapeutics	$4.3B	n/m	n/m	−61%	n/m	n/m
EWTXEdgewise Therapeutics	$4.3B	n/m	n/m	n/m	n/m	n/m
INDVIndivior Pharmaceuticals	$4.1B	12.4×	3.1×	+13%	26.7%	n/m
TNGXTango Therapeutics	$3.9B	n/m	73.1×	+121%	n/m	n/m
ARQTArcutis Biotherapeutics	$3.9B	142×	8.5×	+76%	6.1%	n/m
LQDALiquidia	$3.8B	30.7×	8.5×	n/m	30.7%	n/m
ABCLAbCellera Biologics	$3.6B	n/m	54.8×	+101%	n/m	n/m
OGNOrganon	$3.6B	17.9×	0.6×	−2%	3.4%	n/m
XENEXenon Pharmaceuticals	$3.4B	n/m	n/a	−100%	n/a	n/m
ACADAcadia Pharmaceuticals	$3.4B	n/m	3.0×	+12%	33.4%	n/m
IDYAIDEAYA Biosciences	$3.3B	n/m	14.3×	n/m	−74.8%	n/m
ELVNEnliven Therapeutics	$3B	n/m	n/m	n/m	n/m	n/m
AMLXAmylyx Pharmaceuticalscaveat	$3B	n/m	n/m	n/m	n/m	n/m
PBLSParabilis Medicinescaveat	$3B	n/m	n/m	n/m	n/m	n/m
DYNDyne Therapeutics	$2.9B	n/m	n/m	n/m	n/m	n/m
IRONDisc Medicine	$2.9B	n/m	n/m	n/m	n/m	n/m
VKTXViking Therapeutics	$2.8B	n/m	n/a	n/m	n/a	n/m
NRIXNurix Therapeutics	$2.8B	11.0×	3.9×	n/m	42.0%	n/m
ZLABZai Lab	$2.7B	n/m	6.0×	+5%	−41.9%	n/m
VRDNViridian Therapeutics	$2.5B	n/m	35.6×	n/m	n/m	n/m
BHCBausch Health Companies	$2.4B	n/m	0.2×	+10%	−10.1%	n/m
SUPNSupernus Pharmaceuticals	$2.4B	n/m	2.8×	+25%	−13.2%	n/m
RCUSArcus Biosciences	$2.4B	n/m	20.2×	−55%	n/m	n/m
NAMSNewAmsterdam Pharma	$2.4B	n/m	n/m	−89%	n/m	n/m
MBXMBX Biosciences	$2.3B	n/m	n/m	n/m	n/m	n/m
SLSSELLAS Life Sciences	$2.3B	n/m	n/m	n/m	n/m	n/m
PBHPrestige Consumer Healthcare	$2.3B	13.4×	2.0×	−1%	15.6%	n/m
AUPHAurinia Pharmaceuticals	$2.2B	n/m	7.2×	+20%	n/m	n/m
PGENPrecigencaveat	$2.2B	n/m	n/m	n/m	n/m	n/m
PRGOPERRIGO	$2.2B	n/m	0.5×	−4%	−41.9%	n/m
AGIOAgios Pharmaceuticals	$2.2B	n/m	22.5×	+141%	n/m	n/m
HRMYHarmony Biosciencescaveat	$2.1B	11.7×	2.2×	+24%	18.9%	n/m
BHVNBiohaven	$2.1B	n/m	n/m	n/m	n/m	n/m
IMNMImmunome	$2B	n/m	n/a	−100%	n/a	n/m
VERAVera Therapeutics	$2B	n/m	n/m	n/m	n/m	n/m
ZYMEZymeworks	$2B	n/m	53.9×	−70%	n/m	n/m
BRVEBraveheart Biocaveat	$1.9B	n/m	n/m	n/m	n/m	n/m
MRVIMaravai Lifesciences	$1.9B	n/m	9.1×	−5%	−37.1%	n/m
SEPNSepterna	$1.9B	n/m	19.1×	n/m	−24.5%	n/m
SRPTSarepta Therapeuticscaveat	$1.9B	n/m	0.9×	−20%	−6.9%	n/m
XNCRXencor	$1.9B	n/m	17.8×	−29%	n/m	n/m
XERSXeris Biopharma	$1.9B	n/m	5.5×	+36%	−5.1%	n/m
MLYSMineralys Therapeuticscaveat	$1.8B	n/m	n/m	n/m	n/m	n/m
PVLAPalvella Therapeutics	$1.8B	n/m	n/m	n/m	n/m	n/m
TRVITrevi Therapeutics	$1.8B	n/m	n/m	n/m	n/m	n/m
SDGRSchrodinger	$1.8B	n/m	6.9×	+9%	−21.0%	n/m
ZBIOZenas BioPharmacaveat	$1.8B	n/m	n/m	n/m	n/m	n/m
URGNUroGen Pharma	$1.7B	n/m	8.9×	+100%	−51.7%	n/m
ANIPANI Pharmaceuticals	$1.7B	15.4×	1.7×	+31%	11.1%	n/m
KLRAKailera Therapeuticscaveat	$1.7B	n/m	n/m	n/m	n/m	n/m
STOKStoke Therapeutics	$1.6B	n/m	58.6×	−86%	n/m	n/m
NUVBNuvation Biocaveat	$1.6B	n/m	9.4×	n/m	−88.2%	n/m
GENBGenerate Biomedicinescaveat	$1.6B	n/m	n/m	n/m	n/m	n/m
PAHCPhibro Animal Health	$1.6B	15.9×	1.0×	+17%	6.6%	n/m
TRAXFirst Tracks Biotherapeuticscaveat	$1.6B	n/m	n/m	n/m	n/m	n/m
QUREuniQure	$1.6B	n/m	83.3×	+30%	n/m	n/m
CMPSCOMPASS Pathways	$1.5B	n/m	n/m	n/m	n/m	n/m
RAREUltragenyx Pharmaceutical	$1.5B	n/m	2.2×	+17%	−81.7%	n/m
GPCRStructure Therapeutics	$1.5B	n/m	n/m	n/m	n/m	n/m
INVAInnoviva	$1.5B	n/m	3.4×	+19%	81.2%	n/m
ANABAnaptysbiocaveat	$1.5B	10.7×	n/m	n/m	n/m	n/m
PCRXPacira BioSciences	$1.5B	104×	1.9×	+6%	2.0%	n/m
ETONEton Pharmaceuticalscaveat	$1.4B	n/m	n/m	n/m	n/m	n/m
OCULOcular Therapeutix	$1.4B	n/m	27.4×	−8%	n/m	n/m
ORICOric Pharmaceuticals	$1.4B	n/m	n/m	n/m	n/m	n/m
DMRADamora Therapeutics	$1.3B	n/m	n/m	n/m	n/m	n/m
NKTRNektar Therapeutics	$1.3B	n/m	23.3×	−27%	n/m	n/m
LBRXLB Pharmaceuticalscaveat	$1.2B	n/m	n/m	n/m	n/m	n/m
RAPPRapport Therapeuticscaveat	$1.2B	n/m	n/m	n/m	n/m	n/m
TYRATyra Biosciences	$1.2B	n/m	n/m	n/m	n/m	n/m
OPKOpko Health	$1.2B	n/m	2.1×	−11%	−12.4%	n/m
OMEROmeroscaveat	$1.2B	10.9×	n/m	n/m	n/m	n/m
KARDKardigancaveat	$1.2B	n/m	n/m	n/m	n/m	n/m
SNDXSyndax Pharmaceuticals	$1.2B	n/m	4.7×	+223%	−87.5%	n/m
AVLNAvalyn Pharmacaveat	$1.2B	n/m	n/m	n/m	n/m	n/m
BCAXBicara Therapeutics	$1.1B	n/m	n/m	n/m	n/m	n/m
SPTXSeaport Therapeuticscaveat	$1.1B	n/m	n/m	n/m	n/m	n/m
AMPHAmphastar Pharmaceuticals	$1.1B	14.8×	1.5×	+1%	10.8%	n/m
HROWHarrow	$1.1B	n/m	3.9×	+21%	−13.5%	n/m
AVBPArriVent BioPharma	$1B	n/m	n/m	n/m	n/m	n/m
MNKDMannkind	$1B	n/m	2.6×	+30%	−11.1%	n/m
JANXJanux Therapeutics	$1B	n/m	42.4×	n/m	n/m	n/m
MLTXMoonLake Immunotherapeutics	$1B	n/m	n/m	n/m	n/m	n/m
SLNSilence Therapeutics	$929.3M	n/m	n/m	−98%	n/m	n/m
JBIOJade Biosciencescaveat	$927.9M	n/m	n/m	n/m	n/m	n/m
CYRXCryoport	$910.7M	n/m	4.9×	+12%	−20.1%	n/m
VSTMVerastem	$909.3M	n/m	10.4×	n/m	n/m	n/m
RIGLRigel Pharmaceuticals	$899.1M	n/m	3.2×	+3%	n/m	n/m
CRVSCorvus Pharmaceuticals	$885.8M	n/m	n/m	n/m	n/m	n/m
ALMSAlumis	$877.6M	n/m	119×	n/m	n/m	n/m
AKTSAktis Oncologycaveat	$874.9M	n/m	n/m	n/m	n/m	n/m
SVRASavara	$867M	n/m	n/m	n/m	n/m	n/m
OBXObsidian Therapeuticscaveat	$863.6M	n/m	n/m	n/m	n/m	n/m
ANROAlto Neuroscience	$862.1M	n/m	n/m	n/m	n/m	n/m
KURAKura Oncology	$854.9M	n/m	11.1×	n/m	n/m	n/m
ABUSArbutus Biopharmacaveat	$831M	5.4×	4.6×	n/m	84.2%	n/m
APMDApnimedcaveat	$790.6M	n/m	n/m	n/m	n/m	n/m
ARDXArdelyx	$767.5M	n/m	1.7×	+17%	−12.4%	n/m
COLLCollegium Pharmaceutical	$747.5M	18.5×	0.9×	+14%	5.9%	n/m
GERNGeron	$719.6M	n/m	3.5×	+24%	−33.1%	n/m
ANNXAnnexon	$710.9M	n/m	n/m	n/m	n/m	n/m
NVCTNuvectis Pharma	$653.3M	n/m	n/m	n/m	n/m	n/m
GYREGyre Therapeutics	$652.3M	n/m	5.5×	+14%	−15.5%	n/m
DSGNDesign Therapeutics	$640.8M	n/m	n/m	n/m	n/m	n/m
AKTXAkari Therapeutics Plc	$640.6M	n/m	n/m	n/m	n/m	n/m
LXRXLexicon Pharmaceuticalscaveat	$631.8M	n/m	15.2×	−29%	n/m	n/m
WVEWave Life Sciencescaveat	$626.6M	n/m	n/m	n/m	n/m	n/m
CRMDCorMedix	$611.9M	3.7×	1.3×	+281%	40.5%	n/m
SGMTSagimet Biosciences	$595.5M	n/m	n/m	n/m	n/m	n/m
CMMBChemomab Therapeuticscaveat	$592.6M	n/m	n/m	n/m	n/m	n/m
CLYMClimb Biocaveat	$585.3M	n/m	n/m	n/m	n/m	n/m
IMMXImmix Biopharma	$583M	n/m	n/m	n/m	n/m	n/m
ZVRAZevra Therapeutics	$582.6M	10.5×	4.3×	+119%	42.8%	n/m
IRWDIronwood Pharmaceuticalscaveat	$571.7M	4.5×	1.5×	+26%	33.4%	n/m
PBYIPuma Biotechnology	$568.9M	21.2×	2.5×	−3%	11.6%	n/m
OLMAOlema Pharmaceuticalscaveat	$560.9M	n/m	n/m	n/m	n/m	n/m
ACRSAclaris Therapeutics	$552M	n/m	67.2×	−51%	n/m	n/m
STTKShattuck Labscaveat	$551M	n/m	n/m	−67%	n/m	n/m
CTMXCytomX Therapeutics	$505.5M	n/m	27.6×	−87%	n/m	n/m
AQSTAquestive Therapeutics	$502M	n/m	9.3×	+23%	n/m	n/m
ARVNArvinas	$477.3M	45.6×	1.5×	−15%	2.9%	n/m
CBIOCrescent Biopharmacaveat	$476.2M	n/m	n/m	n/m	n/m	n/m
MNPRMonopar Therapeutics	$474.2M	n/m	n/m	n/m	n/m	n/m
NGNENeurogenecaveat	$471.3M	n/m	n/m	n/m	n/m	n/m
DMACDiaMedica Therapeutics	$470.2M	n/m	n/m	n/m	n/m	n/m
BLSMBlossomHill Therapeuticscaveat	$465M	n/m	n/m	n/m	n/m	n/m
PHATPhathom Pharmaceuticals	$464.4M	n/m	1.9×	+110%	−41.3%	n/m
EOLSEvolus	$463M	n/m	1.5×	+14%	−10.8%	n/m
FTHFaeth Therapeutics	$441.4M	n/m	n/m	n/m	n/m	n/m
OVIDOvid Therapeuticscaveat	$421.8M	n/m	n/m	−76%	n/m	n/m
INDPIndaptus Therapeutics	$421M	n/m	n/m	n/m	n/m	n/m
PRTAProthena Corp Public	$421M	n/m	7.7×	n/m	−80.7%	n/m
ALTAltimmunecaveat	$412.4M	n/m	n/m	n/m	n/m	n/m
ASMBAssembly Biosciences	$404M	n/m	5.4×	+125%	−0.1%	n/m
SPRYARS Pharmaceuticals	$400.8M	n/m	3.4×	+4%	n/m	n/m
IBOImpact Biomedicalcaveat	$388.2M	n/m	n/m	n/m	n/m	n/m
RZLTRezolute	$372.9M	n/m	n/m	n/m	n/m	n/m
AVTXAvalo Therapeuticscaveat	$371.7M	n/m	n/m	n/m	n/m	n/m
MPLTMapLight Therapeuticscaveat	$369.6M	n/m	n/m	n/m	n/m	n/m
RLMDRelmada Therapeutics	$348.8M	n/m	n/m	n/m	n/m	n/m
CAPRCapricor Therapeutics	$344.8M	n/m	n/m	n/m	n/m	n/m
ENTAEnanta Pharmaceuticals	$339M	n/m	5.2×	+1%	−96.9%	n/m
AVIRAtea Pharmaceuticals	$324M	n/m	n/m	n/m	n/m	n/m
GALTGalectin Therapeutics	$321.7M	n/m	n/m	n/m	n/m	n/m
EBSEmergent BioSolutions	$319.4M	n/m	0.4×	−10%	−23.0%	n/m
CTNMContineum Therapeuticscaveat	$312.6M	n/m	n/m	n/m	n/m	n/m
TTRXTurn Therapeutics	$306.2M	n/m	n/m	n/m	n/m	n/m
CYPHCypherpunk Technologies	$303.9M	n/m	n/m	n/m	n/m	n/m
BNTCBenitec Biopharmacaveat	$301.7M	n/m	n/m	n/m	n/m	n/m
PRLDPrelude Therapeutics	$289.7M	n/m	12.9×	+220%	n/m	n/m
IRDOpus Genetics	$288.7M	n/m	29.3×	−36%	n/m	n/m
FULCFulcrum Therapeuticscaveat	$280.8M	n/m	n/m	n/m	n/m	n/m
ARCTArcturus Therapeutics	$279.7M	n/m	9.5×	−76%	n/m	n/m
VOGXVogenxcaveat	$259.2M	n/m	n/m	n/m	n/m	n/m
QTTBQ32 Biocaveat	$257.5M	n/m	n/m	n/m	n/m	n/m
ABEOAbeona Therapeutics	$251.6M	n/m	9.9×	n/m	n/m	n/m
RCKTRocket Pharmaceuticals	$251.4M	n/m	n/a	n/m	n/a	n/m
AMRNAmarin Corp Plc	$249M	n/m	1.3×	−15%	−14.6%	n/m
BCYCBicycle Therapeutics	$248.5M	n/m	4.1×	+217%	n/m	n/m
LRMRLarimar Therapeuticscaveat	$244.1M	n/m	n/m	n/m	n/m	n/m
VNDAVanda Pharmaceuticals	$242.5M	n/m	1.1×	+6%	n/m	n/m
LFCRLifecore Biomedicalcaveat	$242.3M	n/m	n/m	n/m	n/m	n/m
IMRXImmuneering	$241.3M	n/m	n/m	n/m	n/m	n/m
LABStandard Biotools	$237.7M	n/m	2.8×	−24%	n/m	n/m
GLSIGreenwich LifeSciences	$235.3M	n/m	n/m	n/m	n/m	n/m
BIOABioAge Labs	$234.1M	n/m	22.6×	+168%	n/m	n/m
LYELLyell Immunopharma	$230.1M	n/m	n/m	−55%	n/m	n/m
SIGASiga Technologies	$224.2M	n/m	4.2×	−70%	−5.2%	n/m
KROSKeros Therapeutics	$223.7M	n/m	14.9×	−94%	n/m	n/m
NATRNatures Sunshine Products	$213.8M	12.0×	0.4×	+7%	3.7%	n/m
BBOTBridgeBio Oncology Therapeutics	$213.3M	n/m	n/m	n/m	n/m	n/m
CAMPCamp4 Therapeutics	$207.1M	n/m	49.1×	+40%	n/m	n/m
RNACCartesian Therapeuticscaveat	$187M	n/m	n/m	n/m	n/m	n/m
ELDNEledon Pharmaceuticalscaveat	$186.9M	n/m	n/m	n/m	n/m	n/m
EVMNEvommunecaveat	$185.1M	n/m	18.5×	n/m	n/m	n/m
ADCTADC Therapeutics SA	$183.8M	n/m	2.3×	+3%	n/m	n/m
CATXPerspective Therapeutics	$183.8M	n/m	n/m	n/m	n/m	n/m
WHWKWhitehawk Therapeutics	$183M	n/m	n/a	−100%	n/a	n/m
KRROKorro Bio	$176.4M	n/m	74.1×	−62%	n/m	n/m
PEPGPepGen	$174.5M	n/m	n/m	n/m	n/m	n/m
ORMPOramed Pharmaceuticalscaveat	$171.8M	n/m	n/m	n/m	n/m	n/m
TRDAEntrada Therapeutics	$171.7M	n/m	36.6×	−94%	n/m	n/m
SIONSionna Therapeutics	$162.8M	n/m	n/m	n/m	n/m	n/m
ALXOALX Oncology	$161.8M	n/m	n/m	n/m	n/m	n/m
ZNTLZentalis Pharmaceuticalscaveat	$158.4M	n/m	n/m	n/m	n/m	n/m
AKBAAkebia Therapeutics	$157.1M	n/m	0.7×	+8%	−13.5%	n/m
UPBUpstream Biocaveat	$150.1M	n/m	47.5×	+16%	n/m	n/m
MGNXMacrogenics	$143.3M	n/m	0.9×	+12%	−8.7%	n/m
DERMJourney Medical	$141.7M	n/m	2.1×	+21%	−9.0%	n/m
RNAAtrium Therapeuticscaveat	$140.3M	n/m	n/m	n/m	n/m	n/m
PYXSPyxis Oncologycaveat	$140.1M	n/m	n/m	n/m	n/m	n/m
HURATuHURA Biosciences	$138.9M	n/m	n/m	n/m	n/m	n/m
CUECue Biopharma	$135.6M	n/m	3.6×	n/m	n/m	n/m
ANTXAN2 Therapeutics	$134M	n/m	n/m	n/m	n/m	n/m
SPRBSpruce Biosciencescaveat	$129.8M	n/m	n/m	n/m	n/m	n/m
NKTXNkarta	$128.2M	n/m	n/m	n/m	n/m	n/m
ORGOOrganogenesis	$127.8M	n/m	0.3×	+7%	−18.4%	n/m
CPIXCumberland Pharmaceuticals	$127.2M	n/m	4.1×	−1%	−34.9%	n/m
FHTXFoghorn Therapeutics	$118.8M	n/m	3.2×	+52%	n/m	n/m
NERVMinerva Neurosciences	$109.8M	n/m	n/m	n/m	n/m	n/m
UNCYUnicycive Therapeutics	$108.4M	n/m	n/m	n/m	n/m	n/m
NRXPNRX Pharmaceuticals	$107.8M	n/m	31.8×	n/m	n/m	n/m
ANIXAnixa Biosciences	$103.9M	n/m	n/m	n/m	n/m	n/m
OKUROnKure Therapeutics	$102.1M	n/m	n/m	n/m	n/m	n/m
IMUXImmunic	$101.1M	n/m	n/m	n/m	n/m	n/m
VTVTvTv Therapeutics	$101M	n/m	2.7×	n/m	−12.9%	n/m
INOInovio Pharmaceuticals	$92.8M	n/m	n/a	−100%	n/a	n/m
COYACoya Therapeutics	$92.4M	n/m	11.5×	n/m	n/m	n/m
PLYXPolaryx Therapeuticscaveat	$92.2M	n/m	n/m	n/m	n/m	n/m
RACCResearch Alliance Corp IIIcaveat	$92.2M	n/m	n/m	n/m	n/m	n/m
GNLXGENELUX	$90.5M	n/m	n/m	n/m	n/m	n/m
TNXPTonix Pharmaceuticals	$88.7M	n/m	3.0×	+196%	n/m	n/m
RLYBRallybio	$88.4M	n/m	137×	−15%	n/m	n/m
QUCYQuantum Cybercaveat	$84.9M	n/m	n/m	n/m	n/m	n/m

The largest 250 of 412.

Rankings of large drugmakers

Other industries in Healthcare

Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.